Pathophysiology and current treatment of intestinal obstruction.
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002176:Candida albicans / Q000472:pathogenicity; D002496:Central Venous Pressure; D003108:Colonic Diseases / Q000503:physiopathology; D003911:Dextrans / Q000627:therapeutic use; D004071:Digitalis Glycosides / Q000627:therapeutic use; D005769:Gastrointestinal Motility; D005934:Glucagon / Q000627:therapeutic use; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D007415:Intestinal Obstruction / Q000209:etiology / Q000503:physiopathology / Q000601:surgery / Q000628:therapy; D007545:Isoproterenol / Q000627:therapeutic use; D008171:Lung Diseases / Q000209:etiology; D010288:Parenteral Nutrition; D010538:Peritonitis / Q000503:physiopathology; D011312:Pressure; D014859:Warfarin / Q000627:therapeutic use; D014882:Water-Electrolyte Balance
D000900:Anti-Bacterial Agents; D003911:Dextrans; D004071:Digitalis Glycosides; D014859:Warfarin; D006493:Heparin; D005934:Glucagon; D007545:Isoproterenol